Being bitten by a rattlesnake in the great outdoors is bad enough. What's even worse is that some Bay Area hospitals are running short of antivenin to treat patients. A production problem with a ...

The family of a 9-year-old Indiana girl bitten by a venomous snake received a medical bill totaling $142,938 that included a $67,957 charge for four vials of antivenin, according to a Kaiser Health ...

When Ray Grasshoff saw his 3-year-old beagle, Jack, tossing a brightly striped snake violently in his mouth on June 9, then rubbing his snout, he remembered a rhyme from his childhood days working ...

LOS ANGELES – Warm weather is luring rattlesnakes from their holes and tourists to the wilderness, creating potentially deadly confrontations at a time when the drug used to treat bites is in short ...

Be extra careful when you go traipsing through the East Bay hills or the Sierra this summer. If you get bitten by a rattlesnake, your local hospital might not have enough antivenin to treat you. A ...

If you’re one of those pet owners who would do anything to save your animal’s life, this is story you will want to hear. A woman from northwest Houston was left in limbo after her dog’s close ...

The rainy season is synonymous with snake season, putting the onus on local hospitals to have antivenin in stock. The UF Health Shands Hospital typically has about 50 vials of antivenin on hand, said ...

The Nogales border checkpoint separates the United States from Mexico. It only takes a few seconds to walk south from Arizona, through a gate in the middle of a hallway, ending up in a foreign country ...

Snakebites can be painful and scary. But they may seem like weak nips after the hospital’s billing department sinks their teeth in. Emergency treatment for a copperhead bite in a 9-year-old Indiana ...

At the dawn of a new snake season, hospitals are facing a temporary shortage of antivenin used to treat the swollen, blackened legs of hikers bitten by rattlers that have slithered out of their winter ...

PHILADELPHIA (CN) - A rattlesnake venom merchant's defamation claims are baseless and its proposal to settle a patent review process amounts to an extortion attempt, an antivenin producer claims in ...